🇮🇳IN
Sign In
EX

EXPLEOSOL

NSE

Expleo Solutions Limited

₹817.25

+17.20(+2.15%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

EXPLEOSOL financial summary

For Mar 2026, Expleo Solutions Limited reported revenue of ₹939 crore, which fell 8.4% from the previous year. Net profit was ₹100 crore, which grew 5.3% year on year, on an operating margin of 16%. Earnings per share came in at ₹64.56. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹939 crore
Net profit₹100 crore
Operating margin16%
EPS₹64.56

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer